Life in North America, you call this an autopsy officer?!-Chapter 480 - 272 Future Development, Establishment of Umbrella Company_2

Chapter 480: Chapter 272 Future Development, Establishment of Umbrella Company_2

These need to be dealt with at the research institute.

Brian bent over and started to look through the project documents Gandob had handed him.

Seeing him flip through the projects, Gandob and Alpha quieted down again.

Shi San felt bored and stretched out his paw to point at Alpha’s coffee.

Alpha looked surprised and whispered, "Do you want to drink it?"

Shi San nodded his head.

Gandob was far more perspicacious and passed over his own coffee right away.

He knew that some wealthy individuals had their pets enhanced, so one couldn’t regard them as mere pets anymore.

In this era, pets, too, could whisper sweet nothings in their owner’s ears.

Brian didn’t pay attention to this interaction between the dog and the two people.

He was looking through the projects in hand with a frown.

These projects looked decent, but they lacked uniqueness.

The biggest project was the medical aesthetics project for blood exchange.

The effect of this project was acceptable, by using a special blood exchange process coupled with specially cultivated strains, it could allow middle-aged and elderly individuals to regain a relatively young appearance without undergoing cosmetic surgery.

However, this project was only useful to ordinary people.

Moreover, the technological methods for this project were not mature enough for immediate market deployment.

The key issue was that, after Benjamin’s death, people from Black Light Biotechnology Company had pulled out all the researchers responsible for this project.

Actually, Brian had been aware of this project for a long time because the former head of Aiden Research Institute was a victim in his case, named Mycroft.

Professor Mycroft had chosen suicide to protect his hustling wife, which had only then allowed Benjamin to succeed to the position, coming out of NW to take over as the new head of Aiden Research Institute, setting the stage for the subsequent events.

Speaking of which, after Professor Mycroft’s suicide, Brian had even obtained a portrait of the "Curse Pattern" in the meeting room of the institute.

That portrait was still lying under his office desk.

It all came full circle.

Brian had not expected that the research institute would now be his own.

That was fate.

Regathering his thoughts.

Brian looked over the subsequent research projects.

The second project was about treating hair loss.

The person responsible for this project had been taken away by the Black Light Biotechnology Company.

The third project was on myopia studies.

The person in charge of this project was still there and on the cusp of producing results, but upon applying for live experiments, they received a warning from the eyeglasses industry association, and the project was directly canceled.

The fourth project was a comprehensive research project.

It included various types of secondary developments for adults, rapid body shaping using special strains, secondary skeletal development for growing taller, and so on.

Yes, it included the kinds of development you are thinking about.

It had huge potential for profit.

The only problem was that researchers for these projects had also been taken away by the people from Black Light Biotechnology Company.

Those guys acted ruthlessly, not leaving Brian any opportunity to pick up the ready-made success.

There were some other eccentric research projects in the back.

However, they all seemed like castles in the air, apparently just to swindle research funds.

Brian put away the project documents.

He sighed.

If you looked at the content of the projects, any one of them could make money if successfully researched.

But there’s no one!

The Black Light Biotechnology Company had simply left him with nothing but an empty shell of a research institute.

Well, a shell was still something.

At least the land, building, and those high-end research equipment were his own.

Brian looked at Gandob seriously, "You’ve been with Aiden Research Institute for a long time and even served as the acting head for a while. Going forward, our institute is going to lose the technical and financial support from the parent company and we will need to take care of recruiting researchers ourselves. Do you have any suggestions?"

Gandob immediately realized this was a test from the boss.

If he answered well, he could continue to earn a high salary and enjoy a luxurious life.

If he answered poorly, he might have to sell off his mansion, as the property tax would be a burden every year.

Gandob had already prepared his thoughts well in advance.

He organized his language and confidently said,

"Boss, in terms of research, I think we should continue to focus on the blood exchange medical aesthetics project.

This project does not involve enhancement, nor does it need to consider the issue of life extension, making it easy to pass regulatory approval and go to market. We also have sufficient technical accumulation. The key point is that currently there are too many biological research institutions on the market, many projects overlap, but not many are focusing on this segment.

As long as we can lower the costs and ensure safety, we can take advantage of the largest demographic, the middle class, and part of the wealthy individuals."

Hearing this, Brian nodded.

Society was highly distorted.

Biotechnological progress had surged thanks to the Mutant outbreak, but constrained by the "Global Biotechnology Embargo" treaty, most biotech could not be applied to civilian life.

Even those wealthy individuals without the right channels couldn’t access Enhancement Reagents; at best, they could buy some unsafe products leaked onto the black market.

Only the real wealthy who had joined official organizations or the staff of these organizations could enjoy this biotechnological advancement.

The Aiden Research Institute’s blood exchange medical aesthetics technology was a borderline project.

It had noticeable medical aesthetics effects without genetic aspects, so it wasn’t controlled by the "Global Biotechnology Embargo" treaty and could pass approval.

"The project is fine, but what about the researchers?

We don’t have many researchers left now, and most of them are newcomers who joined not long ago, responsible for menial tasks."

Brian agreed with Gandob’s suggestion while posing the question in return.